Panacea Biotec Share Price (PANACEABIO)
as on
| Source : NSE
Panacea Biotec Stock Performance
as on August 22, 2025 at 4:01 PM IST
Day's Low
Day's High
₹402.75₹415.05
1.32%
Downside
1.69%
Upside
52 Week's Low
52 Week's High
₹177.3₹581.956.56%
Downside
42.57%
Upside
| Market Stats | |
| Previous Close | ₹403.10 |
| Open | ₹403.10 |
| Volume | 95.72K |
| Upper Circuit | ₹483.70 |
| Lower Circuit | ₹322.50 |
| Day's Low | ₹402.75 |
| Day's High | ₹415.05 |
| 52 Week Low | ₹177.3 |
| 52 Week High | ₹581.9 |
| Returns % | |
| 1 Month Return | -3.51 % |
| 3 Month Return | -20 % |
| 1 Year Return | + 95.26 % |
| 3 Year Return | + 201.83 % |
| 5 Year Return | + 129.26 % |
Panacea Biotec Stock Fundamentals & Key Indicators
Check Panacea Biotec market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹2,469.02 Cr
Return on Equity (ROE)
0.86
PE Ratio (TTM)
216.72
Return on capital employed (ROCE)
3.26
Industry PE ratio
43.37
Beta (LTM)
0.94
P/B Ratio
2.42
Dividend Yield
0PEG Ratio
33.86
Quarterly Earnings Growth YOY
-124.94
EPS (TTM)
-0.25
Sector
Pharmaceuticals
Book Value
133.94
Technical Analysis
Bearish
View Technical Analysis
Panacea Biotec Stock's Interest Amongst Investors
Panacea Biotec Stock Valuation
Track how Panacea Biotec P/E has moved over time to understand its valuation trends.
Panacea Biotec in the last 5 years
Lowest (-915.62x)
April 25, 2024
Industry (43.37x)
August 21, 2025
Today (216.72x)
August 21, 2025
Highest (235.24x)
July 17, 2025
Today’s Price to Earnings Ratio: 216.72x
Panacea Biotec Ltd Financial Results
Get the annual and quarterly financial summary of Panacea Biotec Ltd, including revenue, profit, loss and more.
Panacea Biotec Earnings and Dividends
View detailed summary of the earnings and dividend history of Panacea Biotec.
Panacea Biotec Ltd Earnings Results
Panacea Biotec Ltd’s net profit jumped 125.63% since last year same period to ₹4.05Cr in the Q1 2025-2026. On a quarterly growth basis, Panacea Biotec Ltd has generated 314.29% jump in its net profits since last 3-months.
Read More about Earnings ResultsPanacea Biotec Ltd Dividends May,2011
In the quarter ending March 2011, Panacea Biotec Ltd has declared dividend of ₹0.75 per share on 13 May 2011 - translating a dividend yield of 0.19%.
Read More about Dividends
Panacea Biotec Stock Shareholding Pattern
View the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Panacea Biotec.
| Investors | Holdings % | Quarterly Trend | 3M change |
|---|---|---|---|
| Promoter Holdings | 72.48% | 0.00 | |
| Foreign Institutions | 0.78% | ||
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 25.22% | 1.42 | |
| Others | 1.52% | 1.86 |
Panacea Biotec Ltd vs Peers
Compare market cap, revenue, PE, and other key metrics of Panacea Biotec with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 2,469.02 | 25.85% | 0.53 | -2 | 559 | |
| NA | 144.70 | 17.83% | 0.84 | 7 | 339 | |
| NA | 509.12 | 22.09% | 0.00 | NA | NA | |
| NA | 732.08 | 31.15% | 0.51 | 421 | 1,280 | |
| NA | 6.03 | -7.89% | 0.00 | -6 | NA |
Panacea Biotec News & Key Events
Latest news and events in one place to help you make informed investing decisions in Panacea Biotec.
Panacea Biotec's Dengue Vaccine Trial Progressing Well - 13 Jul, 2025
The ICMR reports that enrolment for the phase-III clinical trial of Panacea Biotec's dengue vaccine, DengiAll, is on track to complete by October, with no safety concerns noted in initial trials.Panacea Biotec Settles Arbitration with Apotex - 09 Jul, 2025
Panacea Biotec Pharma Ltd. has settled arbitration disputes with Apotex Inc., receiving a net USD 2 million. The agreement modifies profit-sharing for Paclitaxel supply in Canada and the USA, enhancing profitability.
Insights on Panacea Biotec Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 24.86% to 25.22% in Jun 2025 quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -1.89 Cr → 4.05 Cr (in ₹), with an average increase of 146.7% per quarter
- POSITIVE IMPACT
Best in 3 Years
In the last 3 years, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 168.83 Cr → 183.69 Cr (in ₹), with an average increase of 8.1% per quarter
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, PANACEABIO has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTPromoter Holding Unchanged
Promoters holdings remained unchanged at 72.48% of holdings in Jun 2025 quarter
NEGATIVE IMPACTFII Holding Down
Foreign Institutions have decreased holdings from 1.16% to 0.78% in Jun 2025 quarter
- NEGATIVE IMPACT
Price Dip
In the last 3 months, PANACEABIO stock has moved down by -20.0%
About Panacea Biotec Ltd
Revenue: ₹166.70Cr as on June 2025 (Q1 FY26)
Net Profit: ₹3.96Cr as on June 2025 (Q1 FY26)
Listing date: 17 Apr, 1996
Chairperson Name: Rajesh Jain
| Organisation | Panacea Biotec Ltd |
| Headquarters | New Delhi |
| Industry | Pharmaceuticals |
| CEO | Rajesh Jain |
| E-voting on shares | Click here to vote |
FAQs
What is Panacea Biotec share price today?
Panacea Biotec share price today stands at ₹408.15, Open: ₹403.1, Previous Close: ₹403.1, High: ₹415.05, Low: ₹402.75, 52 Week High: ₹581.9, 52 Week Low: ₹177.3 as on .
How to buy Panacea Biotec shares ?
To buy Panacea Biotec shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for PANACEABIO or Panacea Biotec Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Panacea Biotec shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is today's traded volume of Panacea Biotec?
Today's traded volume of Panacea Biotec is 95.72K. Which means that 95.72K shares of Panacea Biotec were bought and sold on the stock market during today's trading session.
What is Panacea Biotec's market cap today?
Today's market capitalisation of Panacea Biotec is ₹2,469.02 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
What is the 52 week high and 52 week low range of Panacea Biotec?
Panacea Biotec’s 52 week high is ₹581.9 and 52 week low is ₹177.3. The current share price of Panacea Biotec is ₹408.15, which is -29.86% down from its 52 week high and 130.20% up from its 52 week low.